Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Jul 29;25(20):6044–6051. doi: 10.1158/1078-0432.CCR-19-0798

Table 4:

Response Details for the 5 stratum 2 responders

Patient ID Prior AB* Baseline Curie Score Baseline BM** score Treatment Courses Best Response Time to event (months)***
4 No 8 2 10 PR No event****
24 No 1 1 8 CR 8
37 No 9 1 10 PR No event****
48 No 0 2 10 CR 70*****
50 No 4 2 10 CR 13
*

AB = anti-GD2 antibody

**

BM = bone marrow

***

Time to progression from start of therapy

****

Patient received XRT after completing protocol therapy, no evidence of disease 5 years off therapy

*****

Relapse diagnosed on surveillance MIBG done 5 years off therapy